Kamada Ltd. operates plasma collection centers in multiple US cities and received FDA approval for its supplement.
3 reports, 1 independent
Updated Jul 20
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kamada Ltd. operates plasma collection centers in multiple US cities and received FDA approval for its supplement.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Kamada received FDA approval for its plasma supplement and plans EMA approval for its Houston site.1 source
Kamada launched biosimilar products in Israel following FDA approval.1 source
Keep exploring
The entities involved
-
Kamada Ltd.
pharmaceutical company
- FDA
Coverage
Newest first; wire copies grouped- GlobeNewswireKamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas Houston Center Cleared to Commence Commercial Sales of Normal Source Plasma State of the Art Facility has Annual Collec
- GlobeNewswireKamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 Company to Host Conference Call at 8:30am ET REHOVOT, Israel, and HOBOKEN, N.J., Aug. 06, 202